Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral neuropeptide Y receptor Y5 (NPY5R) antagonist
Molecular Target Neuropeptide Y receptor Y5 (NPY5R)
Mechanism of ActionNeuropeptide Y receptor Y5 (NPY5R) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today